Nav: Home

Gutenberg Research College welcomes new fellow and presents Gutenberg Research Award 2016

May 03, 2016

In the nine years since its foundation, the Gutenberg Research College (GRC) has firmly established itself as an institution that promotes top-level research and effectively brings together outstanding research in various fields. The GRC annually welcomes new fellows to the organization and presents the Gutenberg Research Award. This year, the GRC appointed Professor Klaus Müllen as a new fellow and honored Dr. Vishva Dixit with its Gutenberg Research Award 2016.

"In addition to facilitating research by large collaborative projects, we at the GRC also recognize the achievements of individual researchers and use our fellowships to support the efforts of exceptional scientists," said Professor Matthias Neubert, Director of the GRC and Theoretical High Energy Physics group at Mainz University. "Today we have the pleasure of welcoming a very eminent scientist as a new member of our community of fellows as well as presenting the Gutenberg Research Award to a distinguished international researcher." The GRC has been giving the award since 2012, with corresponding nominations coming from all faculties at the university. The prize is worth EUR 10,000.

Appointed as the new GRC Fellow was Professor Klaus Müllen, one of the world's most respected scientists in the field of experimental chemistry. Müllen has been Director at the Max Planck Institute for Polymer Research since 1989 and has now begun a three-year period of collaboration at Mainz University in the sector of synthetic chemistry. At JGU, he will be cooperating closely with various work groups at the university. Müllen is known for his numerous research achievements at the interface between experimental synthetic chemistry, polymer chemistry, material sciences, and physics.

The Gutenberg Research Award 2016 goes to biomedical specialist Dr. Vishva Dixit. He received the award for his pioneering research in apoptosis, a form of cellular self-destruction that is also known as programmed cell death. Dixit and his team laid the foundations for decoding the mechanisms underlying programmed cell death at the beginning of the 1990s. This trailblazing research meant that it has become possible to develop new approaches to combating cancer and neurodegenerative illnesses such as Alzheimer's.

Vishva Dixit was also able to demonstrate the existence of a multiprotein complex called inflammasome, which enables the body's own immune system to battle infection. His most recent cutting-edge discoveries are related to the role played by the ubiquitination and deubiquitination of proteins in the development of cancer.

Johannes Gutenberg Universitaet Mainz

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...